But when paired with GLP-1 activity, glucagons effects pivot toward increased energy expenditure through thermogenesis, enhanced fat oxidation and breakdown, and improved metabolic rate
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro
Report persistent GI symptoms to your doctor so dosing can be adjusted if needed
Waist circumference, systolic blood pressure (BP), triglycerides, and non-high-density lipoprotein cholesterol (non-HDL-C) improved significantly, indicating broad cardiometabolic improvements
PMID 27917122
For a full overview of retatrutides mechanism, clinical trial data, dosage reference, and comparison with tirzepatide, see our Retatrutide Peptide Research Guide